Trinity Biotech (Trinity Biotech) Operating Cash Flow per Share

: $-1.30 (TTM As of Sep. 2023)

View and export this data going back to 1995. Start your Free Trial

Trinity Biotech's operating cash flow per share for the three months ended in Sep. 2023 was $-0.61. Trinity Biotech's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2023 was $-1.30.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Trinity Biotech was -342.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Trinity Biotech's Operating Cash Flow per Share or its related term are showing as below:

During the past 13 years, Trinity Biotech's highest 3-Year average Operating Cash Flow per Share Growth Rate was 88.00% per year. The lowest was -60.90% per year. And the median was -2.05% per year.

TRIB's 3-Year OCF Growth Rate is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 2.2
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Trinity Biotech Operating Cash Flow per Share Historical Data

The historical data trend for Trinity Biotech's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trinity Biotech Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Operating Cash Flow per Share

1.40

1.06

5.68

3.17

-0.14

Trinity Biotech Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Operating Cash Flow per Share																0.09	0.24	-0.36	-0.58	-0.61

Competitive Comparison

For the Diagnostics & Research subindustry, Trinity Biotech's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Trinity Biotech Price-to-Operating-Cash-Flow Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Trinity Biotech's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Trinity Biotech's Price-to-Operating-Cash-Flow falls into.

Trinity Biotech Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Trinity Biotech's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (A: Dec. 2022 )	=	Cash Flow from Operations (A: Dec. 2022 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2022 )
	=	-0.921	/	6.747
	=	-0.14

Trinity Biotech's Operating Cash Flow per Share for the quarter that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (Q: Sep. 2023 )	=	Cash Flow from Operations (Q: Sep. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Sep. 2023 )
	=	-4.664	/	7.666
	=	-0.61

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.30

Trinity Biotech Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Trinity Biotech's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Trinity Biotech (Trinity Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Trinity Biotech PLC (NAS:TRIB) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

TRBA:Germany

Address

IDA Business Park, Bray, County Wicklow, Dublin, IRL, A98 H5C8

Website

https://www.trinitybiotech.com

Trinity Biotech PLC is in the business of development, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas, and Rest of World - Ireland of which it derives a majority of its revenues from the Americas segment.